Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-09-25

Clinical Trial Update: Botulinum Toxin Injection to Prevent Ventricular Arrhythmias [Phase 1]

View source ↗

Summary

Phase 1 study evaluating botulinum toxin injections to prevent ventricular arrhythmias in patients with symptomatic ventricular asystole or ventricular tachycar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Symptomatic Ventricular Asystolia, Ventricular Tachycardia | Phase 1 | Status: UNKNOWN